{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:16:23Z","timestamp":1792988183077,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.blre.2010.04.002","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T08:46:57Z","timestamp":1274431617000},"page":"179-190","source":"Crossref","is-referenced-by-count":60,"title":["Thrombopoietic agents"],"prefix":"10.1016","volume":"24","author":[{"given":"Roberto","family":"Stasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Bosworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel S.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenella","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Gordon-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2010.04.002_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tmrv.2004.03.003","article-title":"Relationship between platelet count and bleeding risk in thrombocytopenic patients","volume":"18","author":"Slichter","year":"2004","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2010.04.002_bib2","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.48.1.1","article-title":"Thrombopoietin: understanding and manipulating platelet production","volume":"48","author":"Kaushansky","year":"1997","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.blre.2010.04.002_bib4","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1172\/JCI26891","article-title":"The biogenesis of platelets from megakaryocyte proplatelets","volume":"115","author":"Patel","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2010.04.002_bib5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1172\/JCI106077","article-title":"Thrombokinetics in man","volume":"48","author":"Harker","year":"1969","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2010.04.002_bib6","first-page":"23","article-title":"Mechanisms of platelet production","volume":"15","author":"Stenberg","year":"1989","journal-title":"Blood Cells"},{"key":"10.1016\/j.blre.2010.04.002_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.1983.tb02022.x","article-title":"Fate of senescent megakaryocytes in the bone marrow","volume":"53","author":"Radley","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.04.002_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.V74.1.145.145","article-title":"Characterization of the human burst-forming unit-megakaryocyte","volume":"74","author":"Briddell","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib9","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.V81.11.2844.2844","article-title":"Differentiation and proliferation of hematopoietic stem cells","volume":"81","author":"Ogawa","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib10","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1056\/NEJMra052706","article-title":"Lineage-specific hematopoietic growth factors","volume":"354","author":"Kaushansky","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.04.002_bib11","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI26674","article-title":"The molecular mechanisms that control thrombopoiesis","volume":"115","author":"Kaushansky","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2010.04.002_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000205503","article-title":"Demonstration and some properties of human thrombopoietin in thrombocythaemic sera","volume":"20","author":"Kelemen","year":"1958","journal-title":"Acta Haematol"},{"key":"10.1016\/j.blre.2010.04.002_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0092-8674(90)90410-G","article-title":"A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors","volume":"63","author":"Souyri","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.blre.2010.04.002_bib14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0092-8674(94)90450-2","article-title":"Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl","volume":"77","author":"Bartley","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.blre.2010.04.002_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/369533a0","article-title":"Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand","volume":"369","author":"de Sauvage","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.blre.2010.04.002_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/369568a0","article-title":"Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin","volume":"369","author":"Kaushansky","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.blre.2010.04.002_bib17","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1073\/pnas.91.23.11104","article-title":"The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production","volume":"91","author":"Kuter","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2010.04.002_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/369565a0","article-title":"Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo","volume":"369","author":"Lok","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.blre.2010.04.002_bib19","doi-asserted-by":"crossref","first-page":"13023","DOI":"10.1073\/pnas.91.26.13023","article-title":"Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization","volume":"91","author":"Foster","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2010.04.002_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(94)01008-0","article-title":"Molecular cloning and chromosomal localization of the human thrombopoietin gene","volume":"353","author":"Sohma","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.blre.2010.04.002_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1074\/jbc.270.2.511","article-title":"Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene","volume":"270","author":"Chang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2010.04.002_bib22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/stem.160322","article-title":"Native thrombopoietin: structure and function","volume":"16","author":"Kato","year":"1998","journal-title":"Stem Cells"},{"key":"10.1016\/j.blre.2010.04.002_bib23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V85.4.981.bloodjournal854981","article-title":"Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin","volume":"85","author":"Gurney","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib24","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1182\/blood.V87.12.5382.bloodjournal87125382","article-title":"Thrombopoietin and its alternatively spliced form are expressed in human amygdala and hippocampus","volume":"87","author":"Li","year":"1996","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.blre.2010.04.002_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/stem.5530140712","article-title":"Biological roles for the second domain of thrombopoietin","volume":"14","author":"Foster","year":"1996","journal-title":"Stem Cells"},{"key":"10.1016\/j.blre.2010.04.002_bib26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/bbrc.1995.2239","article-title":"Characterization of the truncated thrombopoietin variants","volume":"213","author":"Wada","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.blre.2010.04.002_bib27","doi-asserted-by":"crossref","first-page":"14849","DOI":"10.1021\/bi961075b","article-title":"Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246","volume":"35","author":"Hoffman","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.blre.2010.04.002_bib28","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1182\/blood.V86.12.4486.bloodjournal86124486","article-title":"Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice","volume":"86","author":"Hokom","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib29","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1073\/pnas.0308530100","article-title":"Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment","volume":"101","author":"Feese","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2010.04.002_bib30","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1073\/pnas.89.12.5640","article-title":"Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily","volume":"89","author":"Vigon","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2010.04.002_bib31","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/j.1460-2075.1993.tb05925.x","article-title":"Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal","volume":"12","author":"Skoda","year":"1993","journal-title":"Embo J"},{"key":"10.1016\/j.blre.2010.04.002_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF00286717","article-title":"The human homolog of the myeloproliferative virus maps to chromosome band 1p34","volume":"83","author":"Le Coniat","year":"1989","journal-title":"Hum Genet"},{"key":"10.1016\/j.blre.2010.04.002_bib33","first-page":"795","article-title":"Structure and transcription of the genomic locus encoding murine c-Mpl, a receptor for thrombopoietin","volume":"10","author":"Alexander","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.blre.2010.04.002_bib34","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1073\/pnas.87.18.6934","article-title":"Structural design and molecular evolution of a cytokine receptor superfamily","volume":"87","author":"Bazan","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2010.04.002_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1006\/geno.1994.1120","article-title":"Structure and transcription of the human c-mpl gene (MPL)","volume":"20","author":"Mignotte","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.blre.2010.04.002_bib36","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1182\/blood.V87.11.4678.bloodjournal87114678","article-title":"Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes","volume":"87","author":"Deveaux","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib37","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/sj.leu.2400845","article-title":"Study of the thrombopoitin receptor in essential thrombocythemia","volume":"11","author":"Kiladjian","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.blre.2010.04.002_bib38","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1006\/cyto.1999.0654","article-title":"Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets","volume":"12","author":"Li","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.blre.2010.04.002_bib39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V85.2.391.391","article-title":"The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets","volume":"85","author":"Debili","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2141.1999.01571.x","article-title":"Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics","volume":"106","author":"Li","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.04.002_bib41","first-page":"6","article-title":"Thrombopoietin: the novel hepatic hormone","volume":"17","author":"Wolber","year":"2002","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.blre.2010.04.002_bib42","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1002\/j.1460-2075.1995.tb00244.x","article-title":"Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity","volume":"14","author":"Alexander","year":"1995","journal-title":"Embo J"},{"key":"10.1016\/j.blre.2010.04.002_bib43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood.V94.1.365.413a46_365_367","article-title":"Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding","volume":"94","author":"Sabath","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib44","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.2909.2909","article-title":"Species specificity and receptor domain interaction of a small molecule TPO receptor agonist","volume":"104","author":"Erickson-Miller","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib45","doi-asserted-by":"crossref","first-page":"14253","DOI":"10.1074\/jbc.M611616200","article-title":"NMR structural studies of interactions of a small, nonpeptidyl Tpo mimic with the thrombopoietin receptor extracellular juxtamembrane and transmembrane domains","volume":"282","author":"Kim","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2010.04.002_bib46","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.283.5404.987","article-title":"Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation","volume":"283","author":"Livnah","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.blre.2010.04.002_bib47","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.283.5404.990","article-title":"Erythropoietin receptor activation by a ligand-induced conformation change","volume":"283","author":"Remy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.blre.2010.04.002_bib48","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1182\/blood.V85.12.3444.bloodjournal85123444","article-title":"Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2","volume":"85","author":"Tortolani","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1196\/annals.1349.018","article-title":"Thrombopoietin and the hematopoietic stem cell","volume":"1044","author":"Kaushansky","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2010.04.002_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0014-5793(95)01072-M","article-title":"Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro","volume":"374","author":"Ezumi","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.blre.2010.04.002_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood.V89.1.101","article-title":"Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization","volume":"89","author":"Sungaran","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood.V94.1.97.413k20_97_105","article-title":"Expression of the thrombopoietin gene in human fetal and neonatal tissues","volume":"94","author":"Wolber","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib53","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V87.2.567.bloodjournal872567","article-title":"Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets","volume":"87","author":"Stoffel","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib54","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V85.10.2720.bloodjournal85102720","article-title":"The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit","volume":"85","author":"Kuter","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib55","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1172\/JCI118005","article-title":"Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia","volume":"95","author":"Nichol","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2010.04.002_bib56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0268-960X(97)90011-4","article-title":"Clinical erythrokinetics: a critical review","volume":"11","author":"Erslev","year":"1997","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2010.04.002_bib57","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V87.6.2154.bloodjournal8762154","article-title":"Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets","volume":"87","author":"Fielder","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2141.2001.03104.x","article-title":"Subcellular localization of thrombopoietin in human blood platelets and its release upon thrombin stimulation","volume":"115","author":"Klinger","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.04.002_bib59","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1182\/blood.V86.10.3668.bloodjournal86103668","article-title":"Murine thrombopoietin mRNA levels are modulated by platelet count","volume":"86","author":"McCarty","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib60","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1182\/blood.V90.9.3444","article-title":"Thrombopoietin is synthesized by bone marrow stromal cells","volume":"90","author":"Guerriero","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib61","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood.V95.12.3758","article-title":"CD40-ligand stimulates myelopoiesis by regulating flt3-ligand and thrombopoietin production in bone marrow stromal cells","volume":"95","author":"Solanilla","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib62","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1055\/s-0037-1616745","article-title":"Hepatic thrombopoietin mRNA is increased in acute inflammation","volume":"86","author":"Wolber","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2010.04.002_bib63","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","article-title":"Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis","volume":"98","author":"Kaser","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib64","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1126\/science.8073287","article-title":"Thrombocytopenia in c-mpl-deficient mice","volume":"265","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.blre.2010.04.002_bib65","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V88.3.803.803","article-title":"Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice","volume":"88","author":"Carver-Moore","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib66","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood.V86.1.54.bloodjournal86154","article-title":"Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates","volume":"86","author":"Farese","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/369571a0","article-title":"cMpl ligand is a humoral regulator of megakaryocytopoiesis","volume":"369","author":"Wendling","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.blre.2010.04.002_bib68","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1182\/blood.V85.7.1719.bloodjournal8571719","article-title":"Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro","volume":"85","author":"Broudy","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib69","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood.V89.8.2679","article-title":"Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients","volume":"89","author":"Bertolini","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood.V89.2.426","article-title":"The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3","volume":"89","author":"Dolzhanskiy","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2141.1996.4761013.x","article-title":"Effects of recombinant human thrombopoietin on megakaryocyte colony formation and megakaryocyte ploidy by human CD34+ cells in a serum-free system","volume":"93","author":"Angchaisuksiri","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2010.04.002_bib72","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI118210","article-title":"Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy","volume":"96","author":"Kaushansky","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2010.04.002_bib73","first-page":"265","article-title":"Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice","volume":"24","author":"Kaushansky","year":"1996","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2010.04.002_bib74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1182\/blood.V92.1.4.413k38_4_10","article-title":"Role of c-mpl in early hematopoiesis","volume":"92","author":"Solar","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib75","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1182\/blood.V87.12.4998.bloodjournal87124998","article-title":"The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells","volume":"87","author":"Sitnicka","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI0215430","article-title":"Thrombopoietin expands hematopoietic stem cells after transplantation","volume":"110","author":"Fox","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.blre.2010.04.002_bib77","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1073\/pnas.96.2.698","article-title":"Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo","volume":"96","author":"Stoffel","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2010.04.002_bib78","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood.V87.10.4158.bloodjournal87104158","article-title":"Relative reactivity of platelets from thrombopoietin- and interleukin-6-treated dogs","volume":"87","author":"Peng","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib79","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood.V86.11.4054.bloodjournal86114054","article-title":"Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin","volume":"86","author":"Chen","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib80","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1182\/blood.V87.11.4664.bloodjournal87114664","article-title":"Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists","volume":"87","author":"Oda","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib81","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0301-472X(01)00623-3","article-title":"Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function","volume":"29","author":"Kojima","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2010.04.002_bib82","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-126-9-199705010-00001","article-title":"Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer","volume":"126","author":"Vadhan-Raj","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2010.04.002_bib83","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1182\/blood.V100.10.3457","article-title":"Recombinant human thrombopoietin: basic biology and evaluation of clinical studies","volume":"100","author":"Kuter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib84","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2006-10-019315","article-title":"New thrombopoietic growth factors","volume":"109","author":"Kuter","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib85","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1182\/blood.V98.12.3241","article-title":"Thrombocytopenia caused by the development of antibodies to thrombopoietin","volume":"98","author":"Li","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib86","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.med.60.042307.181154","article-title":"Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia","volume":"60","author":"Kuter","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.blre.2010.04.002_bib87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1749-6632.2001.tb03582.x","article-title":"Hematopoietic growth factor mimetics","volume":"938","author":"Kaushansky","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.blre.2010.04.002_bib88","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.clpt.2004.08.010","article-title":"Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand","volume":"76","author":"Wang","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.blre.2010.04.002_bib89","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.blre.2010.04.002_bib90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cyto.2003.05.001","article-title":"AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl","volume":"25","author":"Broudy","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.blre.2010.04.002_bib91","first-page":"834","article-title":"Drug evaluation: AMG-531 for the treatment of thrombocytopenias","volume":"7","author":"Rice","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.blre.2010.04.002_bib92","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/pbc.20972","article-title":"AMG 531: an investigational thrombopoiesis-stimulating peptibody","volume":"47","author":"Nichol","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.blre.2010.04.002_bib93","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/stemcells.2008-0366","article-title":"Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist","volume":"27","author":"Erickson-Miller","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.blre.2010.04.002_bib94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.exphem.2004.09.006","article-title":"Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist","volume":"33","author":"Erickson-Miller","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2010.04.002_bib95","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1182\/blood-2006-11-057968","article-title":"Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist","volume":"109","author":"Jenkins","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib96","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.exphem.2009.06.011","article-title":"Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function","volume":"37","author":"Erhardt","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.blre.2010.04.002_bib97","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.2830300404","article-title":"Platelet survival and turnover: important factors in predicting response to splenectomy in immune thrombocytopenic purpura","volume":"30","author":"Siegel","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2010.04.002_bib98","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0002-9343(99)00054-6","article-title":"Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura","volume":"106","author":"Louwes","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.blre.2010.04.002_bib99","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM198904133201505","article-title":"Mechanisms of response to treatment in autoimmune thrombocytopenic purpura","volume":"320","author":"Gernsheimer","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.04.002_bib100","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1056\/NEJM198505023121807","article-title":"An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura","volume":"312","author":"Hoffman","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.04.002_bib101","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2002-05-1475","article-title":"Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro","volume":"102","author":"Chang","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib102","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(08)60203-2","article-title":"Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial","volume":"371","author":"Kuter","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2010.04.002_bib103","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1182\/blood-2008-04-150078","article-title":"Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP","volume":"113","author":"Bussel","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib104","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(09)60402-5","article-title":"Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Bussel","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2010.04.002_bib105","article-title":"Durable and overall platelet responses in patients with chronic idiopathic thrombocytopenic purpura (ITP) during long-term treatment with oral eltrombopag by splenectomy status: the RAISE study","volume":"94","author":"Stasi","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2010.04.002_bib106","first-page":"682-","article-title":"Long-term treatment of chronic immune thrombocytopenic purpura with oral eltrombopag: results from the EXTEND study","volume":"114","author":"Saleh","year":"2009","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1016\/j.blre.2010.04.002_bib107","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.hoc.2009.08.009","article-title":"Infectious causes of chronic immune thrombocytopenia","volume":"23","author":"Stasi","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2010.04.002_bib108","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMoa073255","article-title":"Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C","volume":"357","author":"McHutchison","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.04.002_bib109","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/cncr.22602","article-title":"The incidence and impact of thrombocytopenia in myelodysplastic syndromes","volume":"109","author":"Kantarjian","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.blre.2010.04.002_bib110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1200\/JCO.2009.24.7999","article-title":"Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia","volume":"28","author":"Kantarjian","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.04.002_bib111","first-page":"2765","article-title":"An open-label extension study evaluating the long-term safety and efficacy of romiplostim in thrombocytopenic patients (Pts) with myelodysplastic syndromes (MDS)","volume":"114","author":"Fenaux","year":"2009","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1016\/j.blre.2010.04.002_bib112","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1200\/JCO.2001.19.4.1137","article-title":"Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia","volume":"19","author":"Elting","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.04.002_bib113","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(96)04471-6","article-title":"Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer","volume":"348","author":"Basser","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2010.04.002_bib114","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1056\/NEJM199702063360603","article-title":"Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer","volume":"336","author":"Fanucchi","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2010.04.002_bib115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-132-5-200003070-00005","article-title":"Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer","volume":"132","author":"Vadhan-Raj","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2010.04.002_bib116","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2003.08.003","article-title":"Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia","volume":"21","author":"Vadhan-Raj","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.blre.2010.04.002_bib117","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/blood-2009-05-224766","article-title":"Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim","volume":"114","author":"Kuter","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2010.04.002_bib118","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2165\/00003495-200868070-00002","article-title":"Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura","volume":"68","author":"Stasi","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.blre.2010.04.002_bib119","first-page":"400","article-title":"Oral eltrombopag for the long-term treatment of patients with chronic idiopathic thrombocytopenic purpura: results of a phase III, double-blind, placebo-controlled study (RAISE)","volume":"112","author":"Cheng","year":"2008","journal-title":"ASH Annual Meeting Abstracts"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X10000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X10000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T22:31:52Z","timestamp":1591309912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X10000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":119,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0268960X10000238"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2010.04.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}